Active — Not RecruitingNot Applicable

Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair

Germany180 participantsStarted 2021-03-10

Plain-language summary

Prospective long-term evaluation of the performance and safety of Calistar S for transvaginal pelvic organ prolapse repair in women with anterior POP with or without apical vaginal involvement

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Fertile women
✕. Patients with active or latent infection of the vagina, cervix or uterus
✕. Patients with previous or current vaginal, cervical or uterine cancer
✕. Previous, current or planned pelvic radiation therapy
✕. Known allergy to polypropylene

What they're measuring

Number of Patients with Cure of pelvic organ prolapse

Timeframe: 24 months

Trial details

NCT IDNCT03821142

SponsorPromedon

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-10

View on ClinicalTrials.gov More Pelvic Organ Prolapse trials